000 01138 a2200301 4500
005 20250514222125.0
264 0 _c20050810
008 200508s 0 0 eng d
022 _a0004-8674
024 7 _a10.1111/j.1440-1614.2005.01568.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMendhekar, Dattatrya Namdeorao
245 0 0 _aNeuroleptic malignant syndrome with promethazine.
_h[electronic resource]
260 _bThe Australian and New Zealand journal of psychiatry
_cApr 2005
300 _a310 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdult
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBromocriptine
_xtherapeutic use
650 0 4 _aDopamine Agonists
_xtherapeutic use
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeuroleptic Malignant Syndrome
_xdrug therapy
650 0 4 _aPromethazine
_xadverse effects
700 1 _aAndrade, Chit Ranjan
773 0 _tThe Australian and New Zealand journal of psychiatry
_gvol. 39
_gno. 4
_gp. 310
856 4 0 _uhttps://doi.org/10.1111/j.1440-1614.2005.01568.x
_zAvailable from publisher's website
999 _c15449413
_d15449413